Preclinical efficacy of gemcitabine in MLL-rearranged infant acute lymphoblastic leukemia

Saved in:
Bibliographic Details
Published in:Leukemia 2020-11, Vol.34 (11), p.2898-2902
Main Authors: Wander, Priscilla, Cheung, Laurence C., Pinhan̉«os, Sandra S., Jones, Luke, Kerstjens, Mark, Arentsen-Peters, Susan T.C.J.M., Singh, Sajla, Chua, Grace-Alyssa, Castro, Patricia Garrido, Schneider, Pauline, Dolman, M. Emmy M., Koopmans, Bianca, Molenaar, Jan J., Pieters, Rob, Zwaan, C. Michel, Kotecha, Rishi S., Stam, Ronald W.
Format: Article
Language:English
Subjects:
13/106
13/31
38/47
631/67/1990/283/2125
64/60
692/308/2778
Acute lymphoblastic leukemia
Animals
Antimetabolites, Antineoplastic - pharmacology
Antimetabolites, Antineoplastic - therapeutic use
Antineoplastic Combined Chemotherapy Protocols - adverse effects
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Cancer Research
Critical Care Medicine
Deoxycytidine - analogs & derivatives
Deoxycytidine - pharmacology
Deoxycytidine - therapeutic use
Disease Management
Disease Models, Animal
Drug Evaluation, Preclinical
Gemcitabine
Gene Rearrangement
Genetic Predisposition to Disease
Hematology
Humans
Infant
Intensive
Internal Medicine
Leukemia
Lymphatic leukemia
Medicine
Medicine & Public Health
Myeloid-Lymphoid Leukemia Protein - genetics
Oncology
Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics
Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0887-6924
1476-5551
DOI:10.1038/s41375-020-0895-9